Clinical Research Directory
Browse clinical research sites, groups, and studies.
Cardiac Uptake of 18F Florbetapir in Patients Undergoing Chemotherapy
Sponsor: Medical College of Wisconsin
Summary
This is a pilot study designed to assess for relative change in cardiac 18F Florbetapir uptake in patients with AL cardiac amyloidosis after appropriate chemotherapy.
Official title: A Pilot Study to Evaluate 18F Florbetapir Binding to Cardiac Amyloid in Patients Undergoing Chemotherapy
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
4
Start Date
2020-10-01
Completion Date
2023-05-08
Last Updated
2026-07-16
Healthy Volunteers
No
Conditions
Interventions
F18 Florbetapir (amyvid) cardiac PET/CT imaging
Patients with cardiac amyloidosis (AL) undergoing planned plasma cell directed chemotherapy will have F-18 florbetapir (amyvid) cardiac PET/CT imaging prior to starting chemotherapy and six months after onset of treatment.
Locations (1)
Medical College of Wisconsin
Milwaukee, Wisconsin, United States